What is the share price of Syncom Formulations (India) Ltd (SYNCOMF) today?
The share price of SYNCOMF as on 5th December 2025 is ₹15.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Syncom Formulations (India) Ltd (SYNCOMF) share?
The past returns of Syncom Formulations (India) Ltd (SYNCOMF) share are- Past 1 week: -3.40%
- Past 1 month: -7.58%
- Past 3 months: -10.73%
- Past 6 months: -26.50%
- Past 1 year: -30.50%
- Past 3 years: 93.80%
- Past 5 years: 89.01%
What are the peers or stocks similar to Syncom Formulations (India) Ltd (SYNCOMF)?
The peers or stocks similar to Syncom Formulations (India) Ltd (SYNCOMF) include:What is the market cap of Syncom Formulations (India) Ltd (SYNCOMF) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Syncom Formulations (India) Ltd (SYNCOMF) is ₹1479.56 Cr as of 5th December 2025.What is the 52 week high and low of Syncom Formulations (India) Ltd (SYNCOMF) share?
The 52-week high of Syncom Formulations (India) Ltd (SYNCOMF) is ₹23.87 and the 52-week low is ₹14.10.What is the PE and PB ratio of Syncom Formulations (India) Ltd (SYNCOMF) stock?
The P/E (price-to-earnings) ratio of Syncom Formulations (India) Ltd (SYNCOMF) is 29.93. The P/B (price-to-book) ratio is 4.32.Which sector does Syncom Formulations (India) Ltd (SYNCOMF) belong to?
Syncom Formulations (India) Ltd (SYNCOMF) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Syncom Formulations (India) Ltd (SYNCOMF) shares?
You can directly buy Syncom Formulations (India) Ltd (SYNCOMF) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Syncom Formulations (India) Ltd
SYNCOMF Share Price
15.200.72% (-0.11)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SYNCOMF Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SYNCOMF Performance & Key Metrics
SYNCOMF Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 23.47 | 4.32 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
SYNCOMF Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SYNCOMF Company Profile
Syncom Formulations (India) Limited is a pharmaceutical company that manufactures and markets over 300 pharmaceutical formulations products. It also exports various commodities such as agro and confectionary products and industrial products.
SUNPHARMA
PE Ratio
39.92
39.92
1Y Return
1.01%
1.01%
Buy Reco %
91.67
91.67
TORNTPHARM
PE Ratio
67.21
67.21
1Y Return
13.21%
13.21%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
23.30
23.30
1Y Return
1.34%
1.34%
Buy Reco %
70.00
70.00
DRREDDY
PE Ratio
18.81
18.81
1Y Return
5.10%
5.10%
Buy Reco %
41.94
41.94
LUPIN
PE Ratio
29.12
29.12
1Y Return
0.46%
0.46%
Buy Reco %
72.22
72.22
SYNCOMF Forecast
SYNCOMF Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
SYNCOMF
SYNCOMF
Income
Balance Sheet
Cash Flow
Annual Normal View
SYNCOMF Income Statement
SYNCOMF Income Statement
Annual Normal View
| Financial Year | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 231.68 | 238.86 | 276.92 | 482.45 | 537.35 | |||||
Raw Materials | 137.23 | 142.07 | 158.64 | 318.00 | 448.33 | |||||
| Power & Fuel Cost | 4.38 | 5.31 | 6.13 | 5.62 | ||||||
| Employee Cost | 20.73 | 24.44 | 33.57 | 50.56 | ||||||
| Selling & Administrative Expenses | 29.71 | 27.31 | 31.51 | 40.27 | ||||||
| Operating & Other expenses | 7.59 | 5.22 | 3.68 | -3.75 | ||||||
EBITDA | 32.04 | 34.51 | 43.39 | 71.75 | 89.02 | |||||
| Depreciation/Amortization | 3.95 | 4.54 | 4.72 | 5.19 | 5.29 | |||||
| PBIT | 28.09 | 29.97 | 38.67 | 66.56 | 83.73 | |||||
| Interest & Other Items | 1.93 | 3.40 | 4.72 | 1.05 | 0.83 | |||||
| PBT | 26.16 | 26.57 | 33.95 | 65.51 | 82.90 | |||||
| Taxes & Other Items | 6.39 | 6.50 | 8.63 | 16.07 | 19.85 | |||||
| Net Income | 19.77 | 20.07 | 25.32 | 49.44 | 63.05 | |||||
| EPS | 0.23 | 0.22 | 0.27 | 0.53 | 0.67 | |||||
| DPS | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Payout ratio | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
SYNCOMF Company Updates
SYNCOMF Stock Peers
SYNCOMF Past Performance & Peer Comparison
SYNCOMF Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Syncom Formulations (India) Ltd | 29.93 | 4.32 | — |
| Sun Pharmaceutical Industries Ltd | 39.92 | 6.02 | 0.88% |
| Torrent Pharmaceuticals Ltd | 67.21 | 16.92 | 0.84% |
| Cipla Ltd | 23.30 | 3.93 | 1.05% |
SYNCOMF Stock Price Comparison
Compare SYNCOMF with any stock or ETFCompare SYNCOMF with any stock or ETF
SYNCOMF
SYNCOMF Holdings
SYNCOMF Shareholdings
SYNCOMF Promoter Holdings Trend
SYNCOMF Promoter Holdings Trend
SYNCOMF Institutional Holdings Trend
SYNCOMF Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
SYNCOMF Shareholding Pattern
SYNCOMF Shareholding Pattern
SYNCOMF Shareholding History
SYNCOMF Shareholding History
Foreign Institutions
Mutual Funds Invested in SYNCOMF
Mutual Funds Invested in SYNCOMF
No mutual funds holding trends are available
Top 1 Mutual Funds holding Syncom Formulations (India) Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0007% | Percentage of the fund’s portfolio invested in the stock 0.06% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 94/124 (-5) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing SYNCOMF stock
smallcases containing SYNCOMF stock
Looks like this stock is not in any smallcase yet.
SYNCOMF Events
SYNCOMF Events
SYNCOMF Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SYNCOMF Dividend Trend
No dividend trend available
SYNCOMF Upcoming Dividends
SYNCOMF Upcoming Dividends
No upcoming dividends are available
SYNCOMF Past Dividends
SYNCOMF Past Dividends
Cash Dividend
Ex DateEx DateSep 9, 2022
Final
Final | Div/Share: ₹0.03
Dividend/Share
₹0.03
Ex DateEx Date
Sep 9, 2022
Cash Dividend
Ex DateEx DateSep 21, 2017
Final
Final | Div/Share: ₹0.02
Dividend/Share
₹0.02
Ex DateEx Date
Sep 21, 2017
Cash Dividend
Ex DateEx DateSep 22, 2016
Final
Final | Div/Share: ₹0.02
Dividend/Share
₹0.02
Ex DateEx Date
Sep 22, 2016
Cash Dividend
Ex DateEx DateSep 16, 2015
Final
Final | Div/Share: ₹0.02
Dividend/Share
₹0.02
Ex DateEx Date
Sep 16, 2015
Cash Dividend
Ex DateEx DateSep 18, 2014
Final
Final | Div/Share: ₹0.02
Dividend/Share
₹0.02
Ex DateEx Date
Sep 18, 2014
SYNCOMF Stock News & Opinions
SYNCOMF Stock News & Opinions
Articles & Videos
Earnings
Syncom Formulations (India) consolidated net profit rises 49.41% in the September 2025 quarter
Net profit of Syncom Formulations (India) rose 49.41% to Rs 16.60 crore in the quarter ended September 2025 as against Rs 11.11 crore during the previous quarter ended September 2024. Sales rose 18.97% to Rs 121.72 crore in the quarter ended September 2025 as against Rs 102.31 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales121.72102.31 19 OPM %15.1211.89 - PBDT23.3916.15 45 PBT22.0414.85 48 NP16.6011.11 49 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Syncom Formulations (India) announces board meeting date
Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Syncom Formulations (India) schedules AGM
Syncom Formulations (India) announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Syncom Formulations (India) consolidated net profit rises 106.42% in the June 2025 quarter
Net profit of Syncom Formulations (India) rose 106.42% to Rs 15.75 crore in the quarter ended June 2025 as against Rs 7.63 crore during the previous quarter ended June 2024. Sales rose 33.97% to Rs 116.90 crore in the quarter ended June 2025 as against Rs 87.26 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales116.9087.26 34 OPM %13.5211.98 - PBDT21.5911.40 89 PBT20.2510.10 100 NP15.757.63 106 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Syncom Formulations (India) to table results
Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 8 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Syncom Formulations (India) consolidated net profit rises 139.05% in the March 2025 quarter
Net profit of Syncom Formulations (India) rose 139.05% to Rs 17.69 crore in the quarter ended March 2025 as against Rs 7.40 crore during the previous quarter ended March 2024. Sales rose 99.65% to Rs 148.88 crore in the quarter ended March 2025 as against Rs 74.57 crore during the previous quarter ended March 2024. For the full year,net profit rose 95.30% to Rs 49.43 crore in the year ended March 2025 as against Rs 25.31 crore during the previous year ended March 2024. Sales rose 76.55% to Rs 465.01 crore in the year ended March 2025 as against Rs 263.39 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales148.8874.57 100 465.01263.39 77 OPM %11.9212.63 -11.6411.25 - PBDT24.5811.33 117 70.7038.70 83 PBT23.2910.03 132 65.5033.97 93 NP17.697.40 139 49.4325.31 95 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Syncom Formulations (India) schedules board meeting
Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 19 May 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Syncom Formulations (India) consolidated net profit rises 85.71% in the December 2024 quarter
Net profit of Syncom Formulations (India) rose 85.71% to Rs 13.00 crore in the quarter ended December 2024 as against Rs 7.00 crore during the previous quarter ended December 2023. Sales rose 95.78% to Rs 127.53 crore in the quarter ended December 2024 as against Rs 65.14 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales127.5365.14 96 OPM %11.5511.28 - PBDT18.5710.83 71 PBT17.269.38 84 NP13.007.00 86 Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Syncom Formulations (India) consolidated net profit rises 70.66% in the September 2024 quarter
Net profit of Syncom Formulations (India) rose 70.66% to Rs 11.11 crore in the quarter ended September 2024 as against Rs 6.51 crore during the previous quarter ended September 2023. Sales rose 60.26% to Rs 102.31 crore in the quarter ended September 2024 as against Rs 63.84 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales102.3163.84 60 OPM %11.8910.03 - PBDT16.159.33 73 PBT14.858.45 76 NP11.116.51 71 Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Syncom Formulations (India) to convene board meeting
Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live
1 year agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant